| 1. | Group on assessment of fracture risk and its application to Screening for postmenopausal osteoporosis. Who Technical report Series no. 843. ... Osteoporosis. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. ... |
| 2. | The last decade has witnessed important technological advances in the diagnosis of osteoporosis and an increase in therapeutic options. ... United States for both prevention and treatment of postmenopausal osteoporosis. Clinical trials have demonstrated that both rapidly reduce ... |
| 3. | Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. ... The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab. ... |
| 4. | is FDA-approved for the prevention and treatment of postmenopausal osteoporosis. IV ibandronate is also approved for the treatment ... is approved for the treatment of postmenopausal osteoporosis. One study found that an annual infusion of 5 mg zoledronic acid ... |
| 5. | osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 2002;23:517–523. ... Nelson HD Helfand M Woolf SH Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. ... |
| 6. | bone is approved for the prevention and treatment of postmenopausal osteoporosis. It is also approved to reduce the risk ... Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy ... |
| 7. | Senior Rheumatology PA Quinnipiac University Hamden Connecticut Division of Rheumatology Osteoporosis and Pain Management Arthritis Center of Connecticut Waterbury Connecticut Osteoporosis ... the multidisciplinary care team in the prevention and management of osteoporosis. First untreated high-risk populations and associated stakeholders are identified. ... |
| 8. | Senior Rheumatology PA Quinnipiac University Hamden Connecticut Division of Rheumatology Osteoporosis and Pain Management Arthritis Center of Connecticut Waterbury Connecticut ... issued in October 2004 was instrumental in focusing attention on osteoporosis as a public health problem of growing importance. ... |
| 9. | osteoporosis patients at risk for fracture. Part 1: Rethinking the Pathophysiology of Postmenopausal Bone Loss and Patient Management ... Intervention Cohort (EPIC) Study Group Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study. ... |
| 10. | Orwoll E Ettinger M Weiss S. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000; 343:604-10. ... There are no approved therapies in the United States for men with osteoporosis. The drug alendronate a potent bisphosphonate has been shown ... |
;toggleImage('BtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Broaden Your Search;toggleImage('NtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Narrow Your Search;toggleImage('RtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Related Terms